Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02687165 · ClinicalTrials.gov registry record · NA
Uncovering Neural and Immune Mechanisms of Chronic Pain in Post Treatment Lyme Syndrome
A NA study, sponsored by New York State Psychiatric Institute.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02687165 is a NA study that was terminated before completion, run by New York State Psychiatric Institute. The registered enrollment target is 4 participants.
The verdict
NCT02687165, a NA study, was terminated before completion, sponsored by New York State Psychiatric Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study will investigate (a) neural and immune mechanisms underlying chronic pain in PTLS by comparing a group of PTLS patients and healthy participants on brain imaging, sensory, and immune markers; and (b) assess change in pain, brain imaging (fMRI and MRS), sensory, and immune markers in response to a combination of SNRI and glutamatergic treatment for chronic pain in PTLS (Milnacipran and D-cycloserine).
Interventions
- DRUG Milnacipran and D-cycloserine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-01-16 |
| Est. Completion | 2017-01-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02687165
The ClinicalTrials.gov registry entry for NCT02687165 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Milnacipran and D-cycloserine is the first listed.
NCT02687165 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02687165 about?
NCT02687165 is a clinical study titled "Uncovering Neural and Immune Mechanisms of Chronic Pain in Post Treatment Lyme Syndrome". This study will investigate (a) neural and immune mechanisms underlying chronic pain in PTLS by comparing a group of PTLS patients and healthy participants on brain imaging, sensory, and immune markers; and (b) assess change in pain, brain imaging (fMRI and MRS), sensory, and immune markers in respo...
What is the current status of trial NCT02687165?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2016-01-16. Estimated completion is 2017-01-16.
What interventions are being tested in trial NCT02687165?
The interventions under investigation include: Milnacipran and D-cycloserine (DRUG).
Who is sponsoring clinical trial NCT02687165?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.